NasdaqCM:CORT
NasdaqCM:CORTPharmaceuticals

Corcept Therapeutics (CORT): Margin Dip to 18.4% Challenges Recent Bullish Narratives

Corcept Therapeutics (CORT) posted average earnings growth of 5.5% annually over the past five years, with a 5.6% uptick in the most recent year. Revenue is forecast to climb sharply at 28.2% per year, far outpacing the projected 10.4% growth rate for the US market. While net profit margins have dipped to 18.4% from last year’s 21.9%, high earnings quality and robust growth expectations continue to fuel positive investor sentiment despite a premium valuation. See our full analysis for Corcept...
NasdaqGS:IBRX
NasdaqGS:IBRXBiotechs

ImmunityBio (IBRX): Losses Worsen While 54.9% Projected Revenue Growth Tests Bullish Narratives

ImmunityBio (IBRX) reported another unprofitable period, with losses accelerating at a 15% annual rate over the past five years and net profit margins failing to show improvement. Forecasts suggest the company will remain unprofitable for at least the next three years. However, revenue is projected to surge by 54.9% per year, far outpacing the broader US market's 10.4% average growth rate. Investors now face the challenge of weighing a robust revenue outlook against ongoing losses and high...
NYSE:STWD
NYSE:STWDMortgage REITs

Should Investors Reassess Starwood Property Trust After Increased Investment Activity?

Wondering if Starwood Property Trust is a hidden value opportunity or just another stock riding the waves? Let’s break down what’s driving interest and whether value hunters should take a closer look. Shares have seen modest movement recently, rising 1.1% over the last week but dipping 2.8% across the past month. They are up 5.0% over the last year, showing the stock is definitely on investors’ radar. Starwood Property Trust’s stock price has shifted in the wake of broader trends in real...
NYSE:COR
NYSE:CORHealthcare

Cencora (COR): $713 Million One-Off Loss Challenges Premium Growth Narrative

Cencora (COR) grew its earnings by an average 48.8% per year over the past five years, but growth slowed to just 2.2% in the latest year as revenue is projected to expand at 6.7% annually, trailing the broader US market's 10.5% forecast. Net profit margins fell to 0.6%, compared to 0.7% a year ago, with results affected by a one-off $713.2 million loss for the twelve months ending September 30, 2025. While the outlook calls for 11% annual earnings growth, this pace lags behind the US market's...
NYSE:AIZ
NYSE:AIZInsurance

Assurant (AIZ): Margin Compression Challenges Bullish Community Narratives Despite Fair Value Discount

Assurant (AIZ) posted a net profit margin of 5.8%, down from last year's 6.9%, while earnings have grown at an average rate of 9.7% annually over the past five years. Market forecasts suggest earnings and revenue will continue to rise at 11.9% and 4.1% per year respectively, both trailing the broader US market’s growth outlook. Shares currently trade at a P/E of 15.4x, above industry and peer averages, but the price remains below an internally estimated fair value, putting the spotlight on...
NasdaqGM:NMIH
NasdaqGM:NMIHDiversified Financial

NMI Holdings (NMIH) Margin Holds Above 55%, Reinforcing Value Narrative Despite Slower Growth

NMI Holdings (NMIH) reported a net profit margin of 55.6%, just under last year’s 56.4%, with earnings for the past year up 8.4%. Forward guidance calls for earnings growth of 2.8% per year and revenue growth of 5.9% annually, both trailing forecasts for the broader US market. The company’s solid value signals, low risk profile, and strong track record are factors that may stand out to investors, even as future growth is projected to be somewhat slower than historical averages. See our full...
NYSE:CNX
NYSE:CNXOil and Gas

Has the Recent Jump in Gas Demand Forecasts Changed the Outlook for CNX Resources in 2025?

If you’ve ever wondered whether CNX Resources is a bargain or priced for perfection, you’re not alone. Figuring that out is where smart investing starts. Despite a tough year with the stock down 8.3% over the last 12 months, short-term performance is turning around, up 7.1% just this week. Recent news has focused on increased natural gas demand forecasts and shifting analyst sentiment, which are fueling renewed interest in energy stocks like CNX. Momentum from policy changes around domestic...
NYSE:TEVA
NYSE:TEVAPharmaceuticals

S&P 500 Futures Dip as Debt and Yield Worries Weigh

The Morning Bull - US Market Morning Update Thursday, Nov, 6 2025 US stock futures are drifting lower this morning as investors weigh a jump in long-term bond yields and a new record for household debt. The prospect of higher borrowing costs and elevated debt levels is spurring fresh caution across the market and putting pressure on consumer-focused stocks, as investors focus on the risk that financial strain could temper the economy’s momentum. Act now to uncover undervalued stocks based on...